comprehensive -WSS

comprehensive

author：hotspot 2025-09-30 17:29:17 - browse：51

Illustration of a bear on a red arrow with a bull underneath pushing the arrow upward. -- biotech coverage from STAT — Adobe

This was supposed to be the year of the biotech comeback, when promising new medicines and high-dollar buyouts would reverse a sector-wide slump that dates back to 2021. Instead, biotech stocks have dramatically underperformed the broader market, and the year’s few green shoots are yet to grow into a turnaround.

The closely watched XBI biotech index has fallen more than 10% in 2023, while the S&P 500 rose about 13% in the same period. Privately held companies have struggled to raise new capital without taking a hit to their valuations, and biotech IPOs have been rare in number and inconsistent in return.

The problem, analysts and investors said, is that the generalist investors who steer trillions of dollars of capital have simply soured on biotech. The furor over novel weight loss medicines like Wegovy has largely been a Big Pharma phenomenon, and rising interest rates have steered fund managers away from risky biotech stocks. The sector has gone through boom and bust cycles in the past, and it’s difficult, if not impossible, to predict when the macro winds might change and make biotech as popular as it was in the early days of Covid-19.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： There should be a 'Moonshot' or 'Warp Speed' for rare diseases

WSS

Virtual repurposing can help discover new uses for existing drugs

Are embryos people? Reproductive medicine's future depends on the answer

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

What Congress can do to address the rural doctor shortage

CommonSpirit Health keeps growing, even as it loses money

CDC advisers recommend seasonal use of Pfizer RSV shot

explore

comprehensive

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Doctor of U.S. President Joe Biden says he is fit for duty

Sports medicine is finally prioritizing gender equality

Cholera vaccine supplies dangerously low, outbreaks surging

Hepatitis C has a cure — but many Americans still lack access to it

Why are Kaiser Permanente staff considering a strike?

Medicare proposal to cover medical devices draws a mixed reaction

FDA panel to weigh approval of NurOwn, controversial ALS drug

As demand for Covid shots wanes, Moderna seeks its next success

5 ways to address the shortage of health care workers

hotspot

Why are Kaiser Permanente staff considering a strike?

Laying a path for careers in science

Change Healthcare cyberattack shows risk of industry consolidation

Experts study whether long Covid risk adds up with each reinfection

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Cholera vaccine supplies dangerously low, outbreaks surging

hotspot

entertainment

knowledge

knowledge